To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RRASTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
228 supporting clones for gene RRAS back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BF244575 brain, glioblastoma .a 1 to 647 1 to 636   tiling clone,   636/885
(71 %)
12 diff
(98.7 %id)
BG028428 Bone, osteosarcoma, cell line .a 7 to 780 1 to 766 S2A S3G G4R A5V A6R ...     766/972
(78 %)
52 diff
(94.7 %id)
BC016318 Brain, glioblastoma .a 60 to 1042 5 to 987 exact tiling clone, available from MGC, AAA   983/983
(100 %)
0 diff
(100 %id)
NM_006270.3   .a 60 to 1042 1 to 983 exact RefSeq, AAA   983/983
(100 %)
0 diff
(100 %id)
BI766013 pooled colon, kidney, stomach .a 66 to 677 37 to 648       612/874
(70 %)
13 diff
(98.6 %id)
TI_57149872   .a 66 to 677 37 to 648       612/874
(70 %)
13 diff
(98.6 %id)
CN337900 embryonic stem cells, cell lines H1, H7, andH9 .a 67 to 257 1 to 192       192/198
(96 %)
5 diff
(97.5 %id)
BI488514 brain .a 68 to 891 1 to 823 D23T P25R S27A E28R T29H ...     823/823
(100 %)
9 diff
(99.0 %id)
TI_45379023   .a 68 to 891 60 to 882 D23T P25R S27A E28R T29H ...     823/882
(93 %)
14 diff
(98.5 %id)
BM050829 eye, normal pigmented retinal epithelium .a 69 to 1021 1 to 945 G18V P19T G20W P21A G22R ...     945/945
(100 %)
55 diff
(94.2 %id)
BM850071 myeloma .a 73 to 474 1 to 402       402/402
(100 %)
2 diff
(99.6 %id)
TI_57151288   .a 74 to 890 30 to 856 G10A G17R P19T G20W P21A ...     827/857
(96 %)
21 diff
(97.6 %id)
BI085117 astrocytoma grade IV, cell line, brain .a 75 to 288 1 to 214   fully sequenced,   214/214
(100 %)
0 diff
(100 %id)
BI762232 pooled colon, kidney, stomach .a 80 to 890 1 to 821 G10A G17R P19T G20W P21A ...     821/822
(99 %)
17 diff
(98.0 %id)
BC016286 Uterus, leiomyosarcoma .a 81 to 1044 1 to 964 exact available from MGC, AAA   964/964
(100 %)
0 diff
(100 %id)
BU181691 epithelioid carcinoma, Pancreas .a 81 to 746 1 to 672       672/927
(72 %)
18 diff
(98.1 %id)
DB461581 testis .a 82 to 567 1 to 486       486/486
(100 %)
2 diff
(99.6 %id)
BF726003 eye, Iris .a 88 to 477 1 to 390       390/390
(100 %)
2 diff
(99.5 %id)
BQ672497 epidermoid carcinoma, cell line, salivary gland .a 88 to 637 1 to 550       550/1126
(48 %)
14 diff
(98.8 %id)
BG424028 Kidney, renal cell adenocarcinoma .a 89 to 845 1 to 741 F104S L105C L106W V107C F108S ...     741/775
(95 %)
27 diff
(96.6 %id)
BG421315 Kidney, renal cell adenocarcinoma .a 89 to 875 1 to 783 T9Q R11G R13G R15G G16A ...     783/813
(96 %)
35 diff
(95.7 %id)
BQ938597 epidermoid carcinoma, cell line, lung .a 90 to 892 26 to 848 S3X C70*     822/1027
(80 %)
48 diff
(95.4 %id)
TI_57167676   .a 90 to 785 16 to 714 G10X C215*     699/715
(97 %)
12 diff
(98.4 %id)
CN337897 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 91 to 659 1 to 569       569/569
(100 %)
2 diff
(99.7 %id)
BG827596 muscle, rhabdomyosarcoma .a 92 to 807 1 to 718 D133R D134R F135L V137R V138C ...     718/720
(99 %)
4 diff
(99.5 %id)
BI194058 epithelioid carcinoma cell line, Pancreas .a 93 to 1026 1 to 921 Q151*     921/983
(93 %)
26 diff
(97.4 %id)
DR006978 Spleen .a 94 to 636 7 to 551       545/552
(98 %)
10 diff
(98.2 %id)
TI_57197090   .a 99 to 677 29 to 612       584/826
(70 %)
26 diff
(96.9 %id)
BE885687 leiomyosarcoma, uterus .a 101 to 780 1 to 679 H164X V190C R191P K192E Y193I ...     679/1079
(62 %)
14 diff
(98.8 %id)
BI836722 pooled pancreas and spleen .a 101 to 785 1 to 688 G10X C215*     688/689
(99 %)
6 diff
(99.2 %id)
BQ932209 epidermoid carcinoma, cell line, lung .a 101 to 675 1 to 577       577/1210
(47 %)
9 diff
(99.3 %id)
BI837592 pooled pancreas and spleen .a 102 to 924 1 to 838 R15G G16A G18D P19L D23T ...     818/875
(93 %)
33 diff
(96.3 %id)
BQ227918 epithelioid carcinoma, Pancreas .a 102 to 880 1 to 789 Q194P E195G Q196T E197R L198A ...     789/903
(87 %)
24 diff
(97.4 %id)
TI_57165673   .a 102 to 924 35 to 872 R15G G16A G18D P19L D23T ...     818/909
(89 %)
38 diff
(95.9 %id)
BI820904 pooled brain, lung, testis .a 104 to 677 1 to 579       579/793
(73 %)
17 diff
(97.9 %id)
BQ064590 lymph, lymphoma, cell line .a 104 to 916 1 to 817 exact     817/1021
(80 %)
26 diff
(97.5 %id)
AF493920 brain .a 105 to 761 1 to 657 exact     657/657
(100 %)
1 diff
(99.9 %id)
BT006805   .a 105 to 761 1 to 657 exact     657/657
(100 %)
0 diff
(100 %id)
CR541944   .a 105 to 761 1 to 657 exact     657/657
(100 %)
1 diff
(99.9 %id)
CR541967   .a 105 to 758 1 to 654       654/654
(100 %)
1 diff
(99.9 %id)
CB565905 mixed .a 105 to 448 1 to 344       344/718
(47 %)
2 diff
(99.8 %id)
BP417846 small intestine .a 106 to 313 1 to 210     Submitted on the opposite strand 210/210
(100 %)
9 diff
(95.8 %id)
CN337899 embryonic stem cells, cell lines H1, H7, andH9 .a 110 to 792 1 to 683       683/683
(100 %)
6 diff
(99.2 %id)
CF130816 Chondrosarcoma Lung Metastasis cell lines, lung .a 111 to 542 1 to 431       431/431
(100 %)
3 diff
(99.4 %id)
TI_154192944   .a 111 to 765 51 to 705       655/970
(67 %)
47 diff
(95.2 %id)
CF126390 Chondrosarcoma Lung Metastasis cell lines, lung .a 112 to 717 1 to 605       605/606
(99 %)
5 diff
(99.2 %id)
TI_154189372   .a 112 to 905 52 to 842       791/1026
(77 %)
21 diff
(98.0 %id)
BQ691647 ductal carcinoma, cell line, Pancreas .a 113 to 926 1 to 817       817/971
(84 %)
23 diff
(97.7 %id)
BM821688 stomach .a 113 to 632 1 to 517       517/517
(100 %)
4 diff
(99.3 %id)
BI161128 epithelioid carcinoma cell line, Pancreas .a 114 to 686 1 to 577       577/948
(60 %)
15 diff
(98.5 %id)
CN337898 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 115 to 630 1 to 516       516/516
(100 %)
1 diff
(99.9 %id)
BX360539 Placenta Cot 25-normalized .a 115 to 1024 900 to 1       900/903
(99 %)
32 diff
(96.5 %id)
BE908900 epithelioid carcinoma, Pancreas .a 115 to 981 1 to 853       853/1008
(84 %)
24 diff
(97.7 %id)
ES309327 occipital hair of pubic hypotrichosispatient, skin .a 116 to 684 46 to 616       571/755
(75 %)
17 diff
(97.8 %id)
BG422024 Kidney, renal cell adenocarcinoma .a 117 to 882 1 to 766       766/861
(88 %)
17 diff
(98.1 %id)
W79846 heart .a 120 to 530 5 to 418       414/427
(96 %)
18 diff
(95.8 %id)
BF973806 leiomyosarcoma cell line, uterus .a 121 to 877 1 to 753       753/934
(80 %)
16 diff
(98.3 %id)
BE019479 muscle, rhabdomyosarcoma .a 122 to 630 1 to 508   fully sequenced,   508/508
(100 %)
1 diff
(99.9 %id)
BI820583 pooled brain, lung, testis .a 122 to 780 1 to 658       658/663
(99 %)
5 diff
(99.3 %id)
TI_57197805   .a 122 to 780 37 to 694       658/699
(94 %)
8 diff
(98.9 %id)
BM545944 ovary (pool of 3) .a 127 to 974 23 to 869       847/1181
(71 %)
26 diff
(97.8 %id)
BE019471 muscle, rhabdomyosarcoma .a 128 to 707 1 to 581   fully sequenced,   581/581
(100 %)
13 diff
(97.8 %id)
BE298046 muscle, rhabdomyosarcoma .a 131 to 745 1 to 614       614/615
(99 %)
7 diff
(98.9 %id)
BQ218515 epithelioid carcinoma, Pancreas .a 132 to 786 29 to 689       661/955
(69 %)
19 diff
(98.1 %id)
ES315082 occipital scalp hair, skin .a 136 to 311 1 to 174       174/174
(100 %)
1 diff
(99.5 %id)
BE616055 adenocarcinoma, Pancreas .a 136 to 961 1 to 823       823/911
(90 %)
22 diff
(97.6 %id)
BE616129 adenocarcinoma, Pancreas .a 137 to 923 1 to 787       787/790
(99 %)
21 diff
(97.4 %id)
BE615949 adenocarcinoma, Pancreas .a 137 to 955 1 to 829       824/899
(91 %)
42 diff
(95.4 %id)
CB268364 adipose .a 138 to 633 1 to 496       496/496
(100 %)
4 diff
(99.2 %id)
T53724 placenta .a 140 to 551 1 to 416       416/417
(99 %)
9 diff
(97.9 %id)
BG168314 hypernephroma, cell line, Kidney .a 142 to 736 1 to 592       592/592
(100 %)
24 diff
(96.0 %id)
BE736841 adenocarcinoma, Pancreas .a 143 to 959 1 to 815       815/819
(99 %)
26 diff
(96.9 %id)
TI_154189018   .a 163 to 871 49 to 759       711/1018
(69 %)
22 diff
(97.9 %id)
CF128875 Chondrosarcoma Lung Metastasis cell lines, lung .a 165 to 750 1 to 585       585/585
(100 %)
7 diff
(98.9 %id)
BE561703 Burkitt lymphoma, lymph .a 199 to 1049 28 to 873   AAA   846/873
(96 %)
26 diff
(97.1 %id)
BE268545 Burkitt lymphoma, lymph .a 200 to 909 27 to 728       702/728
(96 %)
25 diff
(96.6 %id)
BE268682 Burkitt lymphoma, lymph .a 200 to 699 25 to 524       500/524
(95 %)
7 diff
(98.7 %id)
BE397417 Burkitt lymphoma, lymph .a 203 to 1032 33 to 857       825/957
(86 %)
21 diff
(97.9 %id)
BI227114 Burkitt lymphoma, lymph .a 212 to 1045 1 to 827       827/843
(98 %)
29 diff
(96.6 %id)
BI224946 Burkitt lymphoma, lymph .a 217 to 1015 1 to 795       795/795
(100 %)
10 diff
(98.8 %id)
BF881017 lung_tumor .a 220 to 637 13 to 428       416/428
(97 %)
7 diff
(98.4 %id)
BI046353 prostate_normal .a 221 to 706 489 to 1       489/491
(99 %)
8 diff
(98.4 %id)
BF738729 bladder_tumor .a 222 to 598 46 to 428       381/457
(83 %)
28 diff
(93.9 %id)
BI046887 prostate_normal .a 222 to 713 17 to 507       491/509
(96 %)
14 diff
(97.3 %id)
BI045872 prostate_normal .a 223 to 706 1 to 482       482/482
(100 %)
8 diff
(98.4 %id)
BI085755 astrocytoma grade IV, cell line, brain .a 227 to 986 759 to 1   fully sequenced,   759/759
(100 %)
9 diff
(98.9 %id)
BE735818 adenocarcinoma, Pancreas .a 229 to 956 1 to 713       713/866
(82 %)
24 diff
(97.3 %id)
W51840 senescent fibroblast .a 232 to 540 1 to 309       309/309
(100 %)
0 diff
(100 %id)
BQ925459 epidermoid carcinoma, cell line, lung .a 249 to 1044 837 to 37   AAA Submitted on the opposite strand 801/847
(94 %)
11 diff
(98.8 %id)
BQ959178 epidermoid carcinoma, cell line, lung .a 249 to 989 1 to 738       738/946
(78 %)
14 diff
(98.6 %id)
BQ316290 colon .a 255 to 448 213 to 21       193/238
(81 %)
8 diff
(96.7 %id)
BQ302225 breast .a 260 to 437 177 to 1       177/177
(100 %)
2 diff
(98.9 %id)
CA425881 cell lines, Chondrosarcoma .a 262 to 1044 802 to 19   AAA   784/784
(100 %)
2 diff
(99.8 %id)
AA315712 colon .a 264 to 688 1 to 425       425/425
(100 %)
0 diff
(100 %id)
AW949342   .a 265 to 785 1 to 522       522/523
(99 %)
2 diff
(99.7 %id)
BX097871 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 271 to 776 1 to 506       506/506
(100 %)
3 diff
(99.5 %id)
BG489835 large cell carcinoma, lung .a 274 to 1049 1 to 774       774/782
(98 %)
16 diff
(98.0 %id)
AA029369 uterus .a 277 to 466 1 to 190       190/192
(98 %)
3 diff
(98.5 %id)
BF992038 placenta_normal .a 279 to 837 14 to 567       554/571
(97 %)
11 diff
(98.1 %id)
BG112442 Bone, osteosarcoma, cell line .a 299 to 1042 1 to 752       752/768
(97 %)
32 diff
(95.9 %id)
BI016622 lung_tumor .a 312 to 673 467 to 106   AAA   362/450
(80 %)
3 diff
(99.4 %id)
AI201108   .a 316 to 1044 755 to 26   AAA   730/731
(99 %)
9 diff
(98.8 %id)
CA423981 cell lines, Chondrosarcoma .a 325 to 1038 735 to 19   AAA   717/720
(99 %)
4 diff
(99.5 %id)
BU624215 cell lines, Enchondroma .a 325 to 1044 739 to 19   AAA   721/724
(99 %)
3 diff
(99.6 %id)
BQ355450 head_neck .a 340 to 816 99 to 580       484/580
(83 %)
13 diff
(97.8 %id)
TI_149277682   .a 351 to 1044 781 to 89   AAA   693/694
(99 %)
9 diff
(98.8 %id)
AI674622 pooled .a 361 to 1038 709 to 33   AAA   589/677
(87 %)
54 diff
(92.1 %id)
AW170521 cervix, tumor .a 366 to 1038 673 to 1       673/673
(100 %)
18 diff
(97.4 %id)
AI434758 Kidney .a 375 to 1045 678 to 1       676/678
(99 %)
14 diff
(98.0 %id)
CD622290   .a 381 to 915 547 to 13       535/547
(97 %)
1 diff
(99.9 %id)
CD622291   .a 381 to 915 1 to 535       535/550
(97 %)
2 diff
(99.7 %id)
BQ348952 head_neck .a 387 to 889 534 to 33       502/534
(94 %)
3 diff
(99.5 %id)
BU600343 mixed (pool of 40 RNAs) .a 420 to 1036 1 to 617       617/617
(100 %)
6 diff
(99.1 %id)
BG260553 bladder, transitional cell papilloma, cell line .a 425 to 1038 1 to 615   AAA   615/615
(100 %)
3 diff
(99.6 %id)
CA425046 cell lines, Chondrosarcoma .a 428 to 1038 630 to 19   AAA   612/612
(100 %)
2 diff
(99.7 %id)
AW009672 colon .a 432 to 1039 608 to 1       608/608
(100 %)
5 diff
(99.2 %id)
BU632905 cell lines, Chondrosarcoma .a 438 to 1038 618 to 19   AAA   600/601
(99 %)
2 diff
(99.7 %id)
AA888855   .a 447 to 1045 599 to 3       597/602
(99 %)
8 diff
(98.7 %id)
TI_154020825   .a 447 to 1044 686 to 89   AAA   598/687
(87 %)
3 diff
(99.6 %id)
CA438659 lung, Metastatic Chondrosarcoma .a 447 to 1044 616 to 19   AAA   598/618
(96 %)
3 diff
(99.6 %id)
AI858444 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 450 to 1039 592 to 1       592/615
(96 %)
15 diff
(97.6 %id)
BM700995 eye, human retina .a 454 to 707 1 to 254   fully sequenced,   254/254
(100 %)
5 diff
(98.1 %id)
BQ961500 leiomyosarcoma, uterus .a 455 to 1046 1 to 593       593/606
(97 %)
17 diff
(97.2 %id)
BQ309057 breast .a 458 to 608 14 to 159       146/160
(91 %)
14 diff
(91.3 %id)
BU677866 lung .a 465 to 1044 598 to 19   AAA   580/580
(100 %)
4 diff
(99.4 %id)
AI674618 Prostate .a 471 to 1044 574 to 1       574/574
(100 %)
3 diff
(99.5 %id)
AW517191 cervix .a 474 to 1045 576 to 5       572/576
(99 %)
6 diff
(99.0 %id)
BX357198 Placenta Cot 25-normalized .a 496 to 1045 1 to 550       550/550
(100 %)
5 diff
(99.1 %id)
CR626325 Placenta Cot 25-normalized .a 497 to 1045 1 to 549       549/549
(100 %)
0 diff
(100 %id)
CF780592 Pooled Chondrosarcoma Tumor cells .a 499 to 1043 7 to 555       549/1368
(40 %)
16 diff
(98.9 %id)
BE819657 breast_normal .a 500 to 794 312 to 20       293/313
(93 %)
13 diff
(95.9 %id)
AW269754 pooled .a 519 to 1045 529 to 3       527/538
(97 %)
0 diff
(100 %id)
BG001764 placenta_normal .a 532 to 899 26 to 393       368/395
(93 %)
8 diff
(98.0 %id)
AI804197 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 537 to 1044 508 to 1       508/508
(100 %)
0 diff
(100 %id)
AI803891 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 555 to 1044 491 to 1       491/491
(100 %)
6 diff
(98.8 %id)
AI336421 lung .a 558 to 1043 489 to 1       489/500
(97 %)
8 diff
(98.4 %id)
BG002030 placenta_normal .a 561 to 830 45 to 320       276/320
(86 %)
10 diff
(96.9 %id)
AI802482   .a 563 to 1045 486 to 4       483/486
(99 %)
1 diff
(99.8 %id)
AI368184 adenocarcinoma, colon .a 576 to 1044 469 to 1       469/469
(100 %)
0 diff
(100 %id)
DB526996 testis .a 581 to 1038 1 to 458     Submitted on the opposite strand 458/458
(100 %)
0 diff
(100 %id)
AW102572 ovary, tumor, 5 pooled (see description) .a 582 to 1038 456 to 1       456/459
(99 %)
5 diff
(99.0 %id)
BE905987 epithelioid carcinoma, Pancreas .a 591 to 1044 1 to 453   AAA   453/453
(100 %)
1 diff
(99.8 %id)
BG748756 eye, normal pigmented retinal epithelium .a 592 to 1041 1 to 450   AAA   450/450
(100 %)
1 diff
(99.8 %id)
AI129442 uterus .a 597 to 1044 465 to 18   AAA   448/448
(100 %)
12 diff
(97.4 %id)
AI276711 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 597 to 1045 454 to 6       449/454
(98 %)
3 diff
(99.4 %id)
BP386038 pancreatic islet .a 599 to 1040 1 to 442     Submitted on the opposite strand 442/443
(99 %)
4 diff
(99.1 %id)
BE206059 muscle, rhabdomyosarcoma .a 600 to 1045 447 to 2   fully sequenced,   446/447
(99 %)
0 diff
(100 %id)
AI674366 Prostate .a 604 to 1045 441 to 2       440/486
(90 %)
8 diff
(98.4 %id)
AA857594 epithelium (cell line), Prostate .a 609 to 1043 435 to 1       435/435
(100 %)
10 diff
(97.8 %id)
AA807129 germinal center B cell .a 615 to 1044 441 to 14   AAA   428/428
(100 %)
4 diff
(99.1 %id)
W74233 heart .a 618 to 1045 429 to 2       428/429
(99 %)
2 diff
(99.6 %id)
AA983438 Kidney, kidney tumor .a 620 to 991 370 to 1       370/370
(100 %)
5 diff
(98.7 %id)
AI283648 Kidney .a 620 to 1045 431 to 7       425/431
(98 %)
1 diff
(99.8 %id)
AA573050 Prostate, prostatic intraepithelial neoplasia - highgrade .a 623 to 1019 405 to 9       397/411
(96 %)
2 diff
(99.6 %id)
AA558135 bone marrow, stem cells .a 624 to 998 374 to 1       374/374
(100 %)
2 diff
(99.5 %id)
AI969219 lung, two pooled squamous cell carcinomas .a 624 to 1045 422 to 1       422/422
(100 %)
0 diff
(100 %id)
BF914220 uterus_tumor .a 632 to 872 2 to 241       240/241
(99 %)
12 diff
(95.1 %id)
AA633369 breast .a 639 to 966 329 to 1       329/329
(100 %)
5 diff
(98.5 %id)
CB049897 Prostate .a 640 to 1045 1 to 399   fully sequenced,   401/401
(100 %)
6 diff
(98.6 %id)
C03752 heart .a 644 to 978 1 to 336       336/336
(100 %)
7 diff
(98.0 %id)
BE206054 muscle, rhabdomyosarcoma .a 646 to 1045 401 to 2   fully sequenced,   400/401
(99 %)
0 diff
(100 %id)
BM672325 eye, human retina .a 646 to 1038 411 to 19   fully sequenced, AAA   393/393
(100 %)
1 diff
(99.8 %id)
BG006985 placenta_normal .a 649 to 870 247 to 26       222/247
(89 %)
0 diff
(100 %id)
AI828629 Prostate .a 650 to 1040 391 to 1       391/391
(100 %)
0 diff
(100 %id)
AW069039 bone marrow stroma .a 657 to 1042 404 to 19   AAA   386/386
(100 %)
0 diff
(100 %id)
AA602995 normal prostate, Prostate .a 660 to 1040 384 to 4       381/384
(99 %)
0 diff
(100 %id)
AI815073 adenocarcinoma, Pancreas .a 669 to 1045 377 to 1       377/377
(100 %)
0 diff
(100 %id)
AJ574495 pectoral muscle (after mastectomy) .a 676 to 1023 11 to 358       348/358
(97 %)
6 diff
(98.4 %id)
T54317 placenta .a 676 to 1039 366 to 1       366/456
(80 %)
9 diff
(98.1 %id)
AW016015   .a 676 to 1044 386 to 18   AAA   369/370
(99 %)
3 diff
(99.2 %id)
F31202 pectoral muscle (after mastectomy) .a 677 to 1027 1 to 352       352/352
(100 %)
1 diff
(99.8 %id)
AA938090 bowel (skin primary), metastatic melanoma to bowel .a 678 to 1045 368 to 2       367/443
(82 %)
0 diff
(100 %id)
AJ573876 pectoral muscle (after mastectomy) .a 679 to 1040 12 to 373       362/376
(96 %)
8 diff
(97.9 %id)
AJ573205 pectoral muscle (after mastectomy) .a 684 to 1037 1 to 353   AAA   353/353
(100 %)
4 diff
(98.9 %id)
AJ572043 pectoral muscle (after mastectomy) .a 685 to 1037 1 to 353   AAA   353/353
(100 %)
3 diff
(99.2 %id)
AI831527 2 pooled tumors (clear cell type), Kidney .a 685 to 1040 358 to 3       356/358
(99 %)
0 diff
(100 %id)
AI658480 Prostate .a 689 to 1044 356 to 1       356/356
(100 %)
0 diff
(100 %id)
AI648524 ovary, tumor, 5 pooled (see description) .a 690 to 1044 355 to 1       355/355
(100 %)
0 diff
(100 %id)
CB048911 Prostate .a 692 to 1044 10 to 362   fully sequenced, AAA   353/362
(97 %)
6 diff
(98.4 %id)
BG194767   .a 694 to 1044 23 to 373   AAA   351/373
(94 %)
6 diff
(98.4 %id)
AI077882 senescent fibroblast .a 695 to 1045 355 to 5       351/355
(98 %)
0 diff
(100 %id)
AI480089 Kidney .a 698 to 1038 341 to 1       341/341
(100 %)
0 diff
(100 %id)
AW271192 Kidney .a 708 to 1036 331 to 3       329/331
(99 %)
0 diff
(100 %id)
AI417898 Prostate .a 713 to 1045 335 to 3       333/335
(99 %)
0 diff
(100 %id)
F32300 pectoral muscle (after mastectomy) .a 715 to 1032 1 to 317       317/317
(100 %)
7 diff
(97.8 %id)
BF852035 lung_normal .a 719 to 871 160 to 5     Submitted on the opposite strand 156/185
(84 %)
0 diff
(100 %id)
CB048910 Prostate .a 734 to 1051 361 to 44   fully sequenced,   318/361
(88 %)
5 diff
(98.7 %id)
BQ013836 placenta .a 735 to 1044 327 to 18   AAA   310/318
(97 %)
0 diff
(100 %id)
AJ573176 pectoral muscle (after mastectomy) .a 772 to 1038 18 to 285   AAA   268/285
(94 %)
6 diff
(97.9 %id)
AJ572326 pectoral muscle (after mastectomy) .a 777 to 1038 8 to 269   AAA   262/269
(97 %)
6 diff
(97.8 %id)
AI581536 colon .a 782 to 1044 262 to 1       262/263
(99 %)
8 diff
(97.0 %id)
BE301274 Kidney, renal cell adenocarcinoma .a 782 to 1045 266 to 2       265/266
(99 %)
0 diff
(100 %id)
AJ574461 pectoral muscle (after mastectomy) .a 802 to 1040 1 to 239       239/243
(98 %)
4 diff
(98.4 %id)
AI675908 adenocarcinoma, Pancreas .a 802 to 1044 243 to 1       243/243
(100 %)
0 diff
(100 %id)
BQ772149 Chondrosarcoma Cell line .a 804 to 1044 259 to 19   AAA   241/250
(96 %)
0 diff
(100 %id)
CB048105 Prostate .a 807 to 1044 10 to 247   fully sequenced, AAA   238/247
(96 %)
6 diff
(97.6 %id)
AA558924 breast .a 809 to 1045 239 to 3       237/239
(99 %)
0 diff
(100 %id)
AA983312 2 pooled tumors (clear cell type), Kidney .a 809 to 1040 233 to 3       231/233
(99 %)
0 diff
(100 %id)
BQ227915 epithelioid carcinoma, Pancreas .a 815 to 1044 1 to 230   AAA   230/230
(100 %)
0 diff
(100 %id)
AI399744 Prostate .a 840 to 1045 214 to 9       206/214
(96 %)
0 diff
(100 %id)
AI401646 Prostate .a 840 to 1045 212 to 7       206/212
(97 %)
0 diff
(100 %id)
CB048104 Prostate .a 850 to 1051 238 to 37   fully sequenced,   202/238
(84 %)
5 diff
(97.9 %id)
BU599340 mixed (pool of 40 RNAs) .a 870 to 1044 1 to 175       175/267
(65 %)
2 diff
(99.3 %id)
AI824595 Prostate .a 883 to 1044 173 to 12   AAA   162/162
(100 %)
2 diff
(98.8 %id)
ES311409 frontal balding hair, skin .a 904 to 1044 164 to 24   AAA Submitted on the opposite strand 141/141
(100 %)
2 diff
(98.6 %id)
BE155692 head_neck .a 925 to 1039 125 to 10     Submitted on the opposite strand 116/125
(92 %)
0 diff
(100 %id)
EC466019 Prostate .a 926 to 1039 125 to 13   AAA   113/115
(98 %)
4 diff
(96.6 %id)
EC475711 Prostate .a 926 to 1032 123 to 22   AAA   102/115
(88 %)
0 diff
(100 %id)
EC499720 Prostate .a 926 to 1036 109 to 4       106/110
(96 %)
0 diff
(100 %id)
EC523818 Prostate .a 926 to 1036 113 to 4       110/115
(95 %)
0 diff
(100 %id)
EC442079 Prostate .a 930 to 1043 111 to 3       109/111
(98 %)
0 diff
(100 %id)
EC458934 Prostate .a 930 to 1043 120 to 8       113/120
(94 %)
0 diff
(100 %id)
EC465197 Prostate .a 930 to 1045 120 to 7       114/120
(95 %)
0 diff
(100 %id)
EC477950 Prostate .a 930 to 1045 115 to 2       114/115
(99 %)
0 diff
(100 %id)
EC492664 Prostate .a 930 to 1045 115 to 1       115/115
(100 %)
1 diff
(99.2 %id)
EC492730 Prostate .a 930 to 1043 117 to 4       114/117
(97 %)
0 diff
(100 %id)
EC500489 Prostate .a 930 to 1045 117 to 3       115/117
(98 %)
0 diff
(100 %id)
EC536698 Prostate .a 930 to 1045 117 to 2       116/117
(99 %)
0 diff
(100 %id)
EC545151 Prostate .a 930 to 1043 114 to 4       111/114
(97 %)
0 diff
(100 %id)
EC572301 Prostate .a 930 to 1043 114 to 3       112/114
(98 %)
0 diff
(100 %id)
EC573775 Prostate .a 930 to 1032 119 to 19       101/119
(84 %)
0 diff
(100 %id)
EC447329 Prostate .a 939 to 1045 104 to 1       104/104
(100 %)
3 diff
(97.2 %id)
EC502614 Prostate .a 939 to 1043 110 to 5       106/110
(96 %)
0 diff
(100 %id)
EC580052 Prostate .a 939 to 1045 102 to 1       102/102
(100 %)
5 diff
(95.1 %id)
CB049896 Prostate .a 970 to 1051 102 to 21   fully sequenced,   82/102
(80 %)
5 diff
(95.1 %id)
BI521523 pooled pancreas and spleen .b 1 to 634 1 to 633 Q42A S43E N45Q E46R V47G ... tiling clone,   633/634
(99 %)
11 diff
(98.3 %id)
DB113946 thymus .c-u 1 to 579 2 to 581 G37X G38R G39R V40R K42Q ... tiling clone, capped   580/580
(100 %)
1 diff
(99.9 %id)
CU449799 epidermis Gene RRAS, variant not shown         This clone was ignored    
CU456073 epidermis Gene RRAS, variant not shown         This clone was ignored    
AA640176 normal prostate, Prostate Gene RRAS, variant not shown         This clone was ignored    
AI367732 lung Gene RRAS, variant not shown         Suspected internal deletion, this clone was ignored    
AI628672 Kidney Gene RRAS, variant not shown       AAA This clone was ignored    
BF590934 colon, colon tumor, RER+ Gene RRAS, variant not shown         This clone was ignored    
BF591029 colon, colon tumor, RER+ Gene RRAS, variant not shown         This clone was ignored    
BF591022 colon, colon tumor, RER+ Gene RRAS, variant not shown         This clone was ignored    
CD367755 Alveolar Macrophage, lung Gene RRAS, variant not shown       AAA Suspected internal deletion, this clone was ignored    
CD743160 Alveolar Macrophage, lung Gene RRAS, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI